4.5 Article

The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation

Journal

JOURNAL OF HEART AND LUNG TRANSPLANTATION
Volume 33, Issue 12, Pages 1248-1254

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2014.06.011

Keywords

lung transplantation; renal function; GFR equations; CKDEPI; MDRD

Funding

  1. Bollinger Research Grant Committee within the Department of Surgery at Duke University Medical Center
  2. Cardiothoracic Surgery Trials Network - National Institutes of Health

Ask authors/readers for more resources

BACKGROUND: Methods for direct measurement of glomerular filtration rate (GFR) are expensive and inconsistently applied across transplant centers. The Modified Diet in Renal Disease (MDRD) equation is commonly used for GFR estimation, but is inaccurate for GFRs >60 ml/min per 1.73 m(2). The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) and Wright equations have shown improved predictive capabilities in some patient populations. We compared these equations to determine which one correlates best with direct GFR measurement in lung transplant candidates. METHODS: We conducted a retrospective cohort analysis of 2/4 lung transplant recipients. Preoperative GFR was measured directly using a radionuclide GFR assay. Results from the MDRD, CKDEPI, Wright, and Cockroft Gault equations were compared with direct measurement. Findings were validated using logistic regression models and receiver operating characteristic (ROC) analyses in looking at GFR as a predictor of mortality and renal function outcomes post-transplant. RESULTS: Assessed against the radionuclide GFR measurement, CKDEPI provided the most consistent results, with low values for bias (0.78), relative standard error (0.03) and mean absolute percentage error (15.02). Greater deviation from radionuclide GFR was observed for all other equations. Pearson's correlation between radionuclide and calculated GFR was significant for all equations. Regression and ROC analyses revealed equivalent utility of the radionuclide assay and GFR equations for predicting post-transplant acute kidney injury and chronic kidney disease (p < 0.05). CONCLUSIONS: In patients being evaluated for lung transplantation, CKDEPI correlates closely with direct radionuclide GFR measurement and equivalently predicts post-operative renal outcomes. Transplant centers could consider replacing or supplementing direct GFR measurement with 'less expensive, more convenient estimation by using the CKDEPI equation. (C) 2014 International Society for Heart and Lung Transplantation. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Reflux Surgery in Lung Transplantation: A Multicenter Retrospective Study

Cynthia L. Green, Brian C. Gulack, Shaf Keshavjee, Lianne G. Singer, Kenneth McCurry, Marie M. Budev, Tammy L. Reece, Anne O. Lidor, Scott M. Palmer, R. Duane Davis

Summary: A multicenter retrospective study found limited benefits of fundoplication for preventing bronchiolitis obliterans syndrome and improving survival compared to reflux disease without surgery after lung transplantation. However, the study had limitations in terms of sample size, follow-up duration, and potential selection bias, highlighting the need for a randomized, prospective study.

ANNALS OF THORACIC SURGERY (2023)

Article Surgery

Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document

Carmen Lefaucheur, Kevin Louis, Anna B. Morris, Jean-Luc Taupin, Peter Nickerson, Anat R. Tambur, Howard M. Gebel, Elaine F. Reed

Summary: This consensus report provides clinical practice recommendations in kidney, heart, lung, and liver transplantation based on expert assessment of quality and strength of evidence regarding the relationship between anti-HLA donor-specific antibodies and transplant outcome. The recommendations address major clinical problems in transplantation, including the clinical implications of positive posttransplant DSA detection, the relevance of posttransplant DSA assessment for diagnosis and treatment management, and the relevance of posttransplant DSA for allograft prognosis and risk stratification.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Correction Cardiac & Cardiovascular Systems

Survival difference between high-risk and low-risk CFTR genotypes after lung transplant (vol 41, pg 1511, 2022)

Emily S. Clausen, Jeremy M. Weber, Megan L. Neely, Kathleen J. Ramos, Laurie D. Snyder

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study

Jamie L. Todd, Jeremy M. Weber, Francine L. Kelly, Megan L. Neely, Andrew Nagler, Dylan Carmack, Courtney W. Frankel, David M. Brass, John A. Belperio, Marie M. Budev, Matthew G. Hartwig, Tereza Martinu, John M. Reynolds, Pali D. Shah, Lianne G. Singer, Laurie D. Snyder, S. Sam Weigt, Scott M. Palmer

Summary: This study found an association between reduced levels of club cell secretory protein (CCSP) in bronchoalveolar lavage fluid (BALF) and the development of chronic lung allograft dysfunction (CLAD) in lung transplant recipients. Decreased CCSP in early post-transplant BALF may indicate an increased risk of later CLAD.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Virology

Evaluation of host cellular responses to Epstein-Barr virus (EBV) in adult lung transplant patients with EBV-associated diseases

Lorenzo Zaffiri, Joshua E. Messinger, Erika J. Bush, Janet S. Staats, Prekshaben Patel, Scott M. Palmer, Kent J. Weinhold, Laurie D. Snyder, Micah A. Luftig

Summary: Reactivation of Epstein-Barr virus (EBV) is often seen in lung transplant recipients (LTRs), but the cellular immune responses to EBV in adult LTRs have not been fully described. In this study, we found significant changes in CD4/CD8 ratio, EBV-specific CD8(+)CD69(+) T cell responses, and NK cell phenotypic changes in adult LTRs with EBV-associated diseases. These findings provide valuable insights into the immune responses to EBV in adult LTRs and may contribute to improved management of EBV-related complications.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Medicine, Research & Experimental

JAK-STAT activation contributes to cytotoxic T cell-mediated basal cell death in human chronic lung allograft dysfunction

Aaditya Khatri, Jamie L. . Todd, Fran L. . Kelly, Andrew Nagler, Zhicheng Ji, Vaibhav Jain, Simon G. Gregory, Kent J. Weinhold, Scott M. Palmer

Summary: Chronic lung allograft dysfunction (CLAD), characterized by decline in pulmonary function and bronchiolitis obliterans, lacks approved therapies. Single-cell RNA-Seq and spatial transcriptomic analysis identified the important role of JAK-STAT signaling in airway epithelial cells in CLAD. Activation of JAK-STAT signaling leads to upregulation of MHC-I in airway basal cells, resulting in cytotoxic T cell-mediated basal cell death. This study provides mechanistic insight and potential therapeutic strategy for CLAD.

JCI INSIGHT (2023)

Article Critical Care Medicine

External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources

Aparna C. Swaminathan, Laurie D. Snyder, Hwanhee Hong, Susanna R. Stevens, Alexander S. Long, Eric Yanchenko, Ying Qiu, Rong Liu, Hongtao Zhang, Aryeh Fischer, Leah Burns, Lisa M. Wruck, Scott M. Palmer

Summary: This study aimed to develop IPF ECs using fit-for-purpose data standards and evaluate their endpoint comparability with the BMS-986020 phase II RCT. The results showed that IPF ECs generated from historical RCT placebo arms had comparable primary treatment effects to that of the original clinical trial, while ECs from real-world data sources did not.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry

Asishana Osho, Marcelo F. F. Fernandes, Ram Poudel, James de Lemos, Haoyun Hong, Juan Zhao, Shen Li, Kathie Thomas, Daniel S. S. Kikuchi, Jessica Zegre-Hemsey, Nasrien Ibrahim, Nilay S. S. Shah, Lori Hollowell, Jacqueline Tamis-Holland, Christopher B. B. Granger, Mauricio Cohen, Timothy Henry, Alice K. K. Jacobs, James G. G. Jollis, Clyde W. W. Yancy, Abhinav Goyal

Summary: This study analyzed data from the American Heart Association registry and found that contemporary systems of care for ST-segment-elevation myocardial infarction (STEMI) in the United States may not effectively reduce racial and ethnic disparities in treatment goals and mortality.

CIRCULATION (2023)

Article Surgery

Repeat pediatric heart transplantation: A united network for organ sharing database analysis

Georgina Rowe, George Gill, M. Mujeeb Zubair, Qiudong Chen, Jason Thomas, Shrishiv A. A. Timbalia, Asishana A. A. Osho, Dominic Emerson, Richard Kim, Michael E. E. Bowdish, Joanna Chikwe, Joseph W. W. Turek

Summary: This study aimed to evaluate the characteristics and outcomes of children undergoing repeat heart transplantation in the United States based on the underlying diagnosis. The long-term outcomes remain poor for patients undergoing repeat heart transplantation, particularly those with an inter-transplant interval <3.6 years. The underlying diagnosis does not impact outcomes after repeat transplantation, after accounting for other risk factors.

CLINICAL TRANSPLANTATION (2023)

Article Surgery

Impact of donor-recipient age-difference in adolescent heart transplantation

George Gill, Georgina Rowe, M. Mujeeb Zubair, Qiudong Chen, Jason Thomas, Peter Chiu, Asishana Osho, Vikram Sood, Kurt R. Schumacher, Dominic Emerson, Michael E. Bowdish, Joanna Chikwe, Francis Fynn-Thompson

Summary: The age difference between donors and recipients has an impact on the survival rate after adolescent heart transplantation. An age difference greater than 11 years is associated with higher long-term mortality.

CLINICAL TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Donation after circulatory death heart procurement strategy impacts utilization and outcomes of concurrently procured abdominal organs

Jason Thomas, Qiudong Chen, Amy Roach, Stanley Wolfe, Asishana A. Osho, Vinay Sundaram, Steven A. Wisel, Dominick Megna, Dominic Emerson, Lawrence Czer, Fardad Esmailian, Joanna Chikwe, Irene Kim, Pedro Catarino

Summary: The utilization and outcomes of concurrently procured DCD livers and kidneys were evaluated in this study. It was found that in-situ thoracoabdominal normothermic regional perfusion was associated with increased utilization of DCD livers and a lower incidence of delayed graft function in concurrently procured DCD kidneys.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

Defining the Temporal Relationship Between Peak Lung Function and Quality of Life Trajectories after Lung Transplantation in a Large Multi-Center Cohort

W. M. Tsuang, Ml Neely, S. M. Palmer, LG. Singer, M. Budev, P. Shah, J. A. Belperio, J. M. Reynolds, L. D. Snyder

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Pharmacology & Pharmacy

Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis

Joao A. de Andrade, Megan L. Neely, Anne S. Hellkamp, Daniel A. Culver, Hyun J. Kim, Timothy Liesching, Leonard J. Lobo, Murali Ramaswamy, Zeenat Safdar, Shaun Bender, Craig S. Conoscenti, Thomas B. Leonard, Scott M. Palmer, Laurie D. Snyder

Summary: This study investigated the impact of antifibrotic therapy on mortality and other outcomes in patients with idiopathic pulmonary fibrosis (IPF) using causal inference methodology. The results suggest that patients with IPF who receive antifibrotic therapy have improved survival but may also have increased risks of respiratory-related hospitalizations and acute worsening of IPF.

CLINICAL THERAPEUTICS (2023)

Article Respiratory System

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

Todd L. L. Astor, Hilary J. J. Goldberg, Laurie D. D. Snyder, Andrew Courtwright, Ramsey Hachem, Tahuanty Pena, Lorenzo Zaffiri, Gerard J. J. Criner, Marie M. M. Budev, Tany Thaniyavarn, Thomas B. B. Leonard, Shaun Bender, Aliaa Barakat, Janis L. L. Breeze, Peter LaCamera

Summary: In patients with idiopathic pulmonary fibrosis, discontinuing anti-fibrotic therapy < 5 medication half-lives before lung transplant may increase the risk of anastomotic and sternal dehiscence, while there were no differences in other intra-operative and post-transplant complications based on the timing of discontinuation of anti-fibrotic therapy.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2023)

No Data Available